PharmaCorp Rx

PharmaCorp Rx Revenue per Share

The Revenue per Share of PharmaCorp Rx (PCRX.V) as of Oct 11, 2026 is 0.18 CAD. In the previous year, Revenue per Share was 0.05 CAD — a change of 260.57% (higher).

Revenue per Share

0.18CAD

YoY

260.57%

Last updated:

Revenue per Share of PharmaCorp Rx is 2025 0.18 CAD. Revenue per Share of PharmaCorp Rx was 2024 0.05 CAD. It decreases by 260.57% higher compared to the previous year.

The PharmaCorp Rx Revenue per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
Date
Revenue per Share
Jan 1, 2021
0.00 CAD
Jan 1, 2022
0.00 CAD
Jan 1, 2023
0.00 CAD
Jan 1, 2024
0.05 CAD
Jan 1, 2025
0.18 CAD
Jan 1, 2026 (e)
0.29 CAD
Jan 1, 2027 (e)
0.56 CAD
The PharmaCorp Rx Revenue per Share history
YEARRevenue per ShareYoY
est0.56CAD+93.87%
est0.29CAD+63.21%
0.18CAD+260.57%
0.05CAD—
0.00CAD—
0.00CAD—
0.00CAD—
Access this data via the Eulerpool API
Get Free API Key

PharmaCorp Rx Stock analysis

What does PharmaCorp Rx do? PharmaCorp Rx is one of the most popular companies on Eulerpool.

Frequently Asked Questions about PharmaCorp Rx stock

Revenue per Share of PharmaCorp Rx is 0.18 CAD in 2025.

Revenue per Share of PharmaCorp Rx changed from 0.05 CAD to 0.18 CAD, representing a 260.57% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Revenue per Share PharmaCorp Rx since 2006 – with annual values, charts, and detailed analysis.

Revenue per Share divides total revenue by shares outstanding, showing how much revenue each share represents.

Access this data via the Eulerpool API
Get Free API Key

Income Statement — PharmaCorp Rx

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — PharmaCorp Rx